The origin and activities of IgA1-containing immune complexes in IgA nephropathy
B Knoppova, C Reily, N Maillard, DV Rizk… - Frontiers in …, 2016 - frontiersin.org
IgA nephropathy (IgAN) is the most common primary glomerulonephritis, frequently leading
to end-stage renal disease, as there is no disease-specific therapy. IgAN is diagnosed from …
to end-stage renal disease, as there is no disease-specific therapy. IgAN is diagnosed from …
Peptidomics and proteomics based on CE‐MS as a robust tool in clinical application: The past, the present, and the future
Capillary electrophoresis combined with mass spectrometry (CE‐MS) has been used for
several years for the investigation of proteins and peptides as biomarkers for diagnosis and …
several years for the investigation of proteins and peptides as biomarkers for diagnosis and …
Urinary proteomics for early diagnosis in diabetic nephropathy
Diabetic nephropathy (DN) is a progressive kidney disease, a well-known complication of
long-standing diabetes. DN is the most frequent reason for dialysis in many Western …
long-standing diabetes. DN is the most frequent reason for dialysis in many Western …
Technical aspects and inter-laboratory variability in native peptide profiling: The CE–MS experience
Mass spectrometry platforms have attracted a lot of interest in the last 2 decades as profiling
tools for native peptides and proteins with clinical potential. However, limitations associated …
tools for native peptides and proteins with clinical potential. However, limitations associated …
Current state of the art for enhancing urine biomarker discovery
M Harpole, J Davis, V Espina - Expert review of Proteomics, 2016 - Taylor & Francis
Introduction: Urine is a highly desirable biospecimen for biomarker analysis because it can
be collected recurrently by non-invasive techniques, in relatively large volumes. Urine …
be collected recurrently by non-invasive techniques, in relatively large volumes. Urine …
Reproducibility evaluation of urinary peptide detection using CE-MS
In recent years, capillary electrophoresis coupled to mass spectrometry (CE-MS) has been
increasingly applied in clinical research especially in the context of chronic and age …
increasingly applied in clinical research especially in the context of chronic and age …
Biomarker discovery in mass spectrometry‐based urinary proteomics
Urinary proteomics has become one of the most attractive topics in disease biomarker
discovery. MS‐based proteomic analysis has advanced continuously and emerged as a …
discovery. MS‐based proteomic analysis has advanced continuously and emerged as a …
Liquid biopsy biomarkers in bladder cancer: a current need for patient diagnosis and monitoring
I Lodewijk, M Dueñas, C Rubio… - International journal of …, 2018 - mdpi.com
Bladder Cancer (BC) represents a clinical and social challenge due to its high incidence
and recurrence rates, as well as the limited advances in effective disease management …
and recurrence rates, as well as the limited advances in effective disease management …
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development
Biomarker research is continuously expanding in the field of clinical proteomics. A
combination of different proteomic–based methodologies can be applied depending on the …
combination of different proteomic–based methodologies can be applied depending on the …
Multiple sclerosis biomarker discoveries by proteomics and metabolomics approaches
Multiple sclerosis (MS) is an autoimmune inflammatory disorder of the central nervous
system (CNS) resulting in demyelination and axonal loss in the brain and spinal cord. The …
system (CNS) resulting in demyelination and axonal loss in the brain and spinal cord. The …